Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Tenaya Therapeutics logo — Scaling new heights in the fight against heart disease

Tenaya Therapeutics

Scaling new heights in the fight against heart disease

Founded 2016 United States South San Francisco, United States 93 employees Post Ipo Equity Total: $373.00M Biopharma, Biotechnology +2

General Information

Company Name Tenaya Therapeutics
Founded Year 2016
Location United States South San Francisco, United States +1
Employees 93
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Post Ipo Equity
Social

Get notified when Tenaya Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Tenaya Therapeutics

Tenaya Therapeutics is a clinical stage biotechnology company founded in 2016 by leading cardiovascular scientists from the David J. Gladstone Institutes and the University of Texas Southwestern Medical Center. The company's slogan "Scaling new heights in the fight against heart disease" reflects its commitment to a bold mission of discovering, designing, developing, and delivering curative therapies that address the underlying drivers of heart disease. Tenaya Therapeutics aims to change the treatment paradigm for heart disease to improve and extend the lives of millions of individuals and families fighting this debilitating disease. The company focuses on advancing a pipeline of disease-modifying therapies developed using its product platforms and core internal capabilities to target defined sub-populations of patients with rare or highly prevalent forms of heart disease. Tenaya Therapeutics operates in the Biopharma, Biotechnology, and Health Care industries and is headquartered in the United States. The company recently secured a significant $50.00M Post-IPO Equity investment on 08 February 2024 from a group of renowned investors including RA Capital Management, The Column Group, Octagon Capital Advisors, PFM Health Sciences, Soleus Capital, Venrock Healthcare Capital Partners, Integral Health Asset Management, and Armistice Capital. This recent investment indicates a strong investor interest in the company's innovative approach to addressing heart disease, positioning Tenaya Therapeutics for further growth and development in the biotechnology and healthcare sectors.

Taxonomy: Clinical stage, Heart disease, Therapeutics, Disease-modifying therapies, Heart failure, Cardiomyopathies, Gene therapy, Precision medicine, Cellular regeneration, Cardiac development, Regenerative medicine, Rare diseases, Cellular reprogramming, iPSC-Cardiomyocytes

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 8
Investor Investor Investor Investor Investor Investor
•••• •••• 		08 Feb 2024
Post-IPO Equity •••••• - 17 Nov 2022
Series C •••••• 2
Investor Investor
01 Mar 2021
Series B •••••• - 03 Oct 2019
Series A •••••• - 06 Dec 2016

Tenaya Therapeutics Alternatives & Competitors

Tenaya Therapeutics vs
Renovacor
Renovacor

Advancing transformative therapies for cardiovascular disease

Post Ipo Equity
6 employees
Biotechnology, Health Care
Compare Tenaya Therapeutics vs Renovacor
Tenaya Therapeutics vs
Ashchi Heart & Vascular Center, PA
Ashchi Heart & Vascular Center, PA United States

Providing high quality, diagnostic treatments & services for patients with diseases of the heart & v...

8 employees
Health Care
Tenaya Therapeutics vs
BEAT BioTherapeutics
BEAT BioTherapeutics

Pioneering Novel Therapies for Heart Disease with Groundbreaking Gene Therapy to Enhance Cardiac Per...

Seed
2-10 employees
Biotechnology, Health and Wellness
Compare Tenaya Therapeutics vs BEAT BioTherapeutics
Also compare with: Tenaya Therapeutics vs Heartseed Inc. Heartseed Inc.

FAQ About Tenaya Therapeutics

Scaling new heights in the fight against heart disease
Tenaya Therapeutics was founded in 2016.
Tenaya Therapeutics is headquartered in South San Francisco, United States.
Tenaya Therapeutics operates in the following industries: Biopharma, Biotechnology, Health Care, Health and Wellness.
Tenaya Therapeutics has approximately 93 employees.
Tenaya Therapeutics has completed 5 funding rounds, raising a total of $373.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Tenaya Therapeutics include Renovacor, Ashchi Heart & Vascular Center, PA, BEAT BioTherapeutics, Kardigan, Heartseed Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tenaya Therapeutics and Renovacor are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Tenaya Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes